TiumBio Co., Ltd.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects (NCT06025552) | TiumBio Co., Ltd. | 2023-08-02 |
| Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors (NCT05784688) | TiumBio Co., Ltd. | 2023-03-10 |
| Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors (NCT05204862) | TiumBio Co., Ltd. | 2021-12-02 |
| TUC3PII-01_TU2670 Phase IIa Clinical Study (NCT05138562) | TiumBio Co., Ltd. | 2021-08-19 |
Track TiumBio Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.